OA08506A - Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. - Google Patents
Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.Info
- Publication number
- OA08506A OA08506A OA59095A OA59095A OA08506A OA 08506 A OA08506 A OA 08506A OA 59095 A OA59095 A OA 59095A OA 59095 A OA59095 A OA 59095A OA 08506 A OA08506 A OA 08506A
- Authority
- OA
- OAPI
- Prior art keywords
- compounds
- prophylaxis
- treatment
- disorders
- agents containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000001777 nootropic effect Effects 0.000 title abstract 3
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000003920 cognitive function Effects 0.000 title 1
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863610391 DE3610391A1 (de) | 1986-03-27 | 1986-03-27 | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08506A true OA08506A (fr) | 1988-07-29 |
Family
ID=6297417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59095A OA08506A (fr) | 1986-03-27 | 1987-03-27 | Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0243645B1 (cs) |
| JP (1) | JPS62240698A (cs) |
| KR (1) | KR870008841A (cs) |
| CN (1) | CN1031267C (cs) |
| AT (1) | ATE102954T1 (cs) |
| AU (1) | AU621278B2 (cs) |
| CA (1) | CA1341064C (cs) |
| CS (2) | CS276385B6 (cs) |
| DD (1) | DD280765A5 (cs) |
| DE (2) | DE3610391A1 (cs) |
| DK (1) | DK172221B1 (cs) |
| EG (1) | EG18175A (cs) |
| ES (1) | ES2061447T3 (cs) |
| FI (1) | FI91876C (cs) |
| HU (2) | HU202118B (cs) |
| IE (1) | IE62456B1 (cs) |
| MA (1) | MA20919A1 (cs) |
| NO (1) | NO178546C (cs) |
| NZ (1) | NZ219764A (cs) |
| OA (1) | OA08506A (cs) |
| PH (1) | PH27210A (cs) |
| PT (1) | PT84564B (cs) |
| RU (1) | RU1836335C (cs) |
| TN (1) | TNSN87045A1 (cs) |
| ZA (1) | ZA872230B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| AU612137B2 (en) * | 1987-04-27 | 1991-07-04 | E.R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| DE3731085A1 (de) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
| DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
| JPH01275529A (ja) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | 晩発性運動障害の抑制治療剤 |
| US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
| US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
| US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| CA2442717A1 (en) * | 2001-03-15 | 2002-09-26 | Saegis Pharmaceuticals, Inc. | Methods for restoring cognitive function following systemic stress |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19575012I2 (de) * | 1980-10-23 | 2002-01-24 | Schering Corp | Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
-
1987
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-18 EP EP87103938A patent/EP0243645B1/de not_active Expired - Lifetime
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Ceased
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-27 OA OA59095A patent/OA08506A/xx unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
- 1987-03-27 CS CS896519A patent/CS276385B6/cs not_active IP Right Cessation
- 1987-03-27 CS CS872126A patent/CS276179B6/cs unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA08506A (fr) | Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. | |
| FR2615394B1 (fr) | Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales | |
| MC2272A1 (fr) | Utilisation de la substance active nommee flupirtine pour combattre des contractures musculaires | |
| IL89031A0 (en) | Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation | |
| FR2541115B1 (fr) | Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses | |
| FR2430408A1 (fr) | Phenethanolamines optiquement actives et leur utilisation therapeutique | |
| EP0261595A3 (en) | Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus | |
| DE69330150D1 (de) | Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge | |
| SE8301038L (sv) | Tiopyranopyrimidinforeningar och syraadditionssalter derav | |
| DE69327207D1 (de) | Tryptamine zur Behandlung von Störungen der circadianen Rhythmik | |
| UA19674A (uk) | Композиція для обробки коhтактhих ліhз | |
| EP0667157A4 (en) | AGENT FOR TREATING CYCLING COMPLAINTS. | |
| IL83586A0 (en) | Substituted hexahydroarylquinolizines and pharmaceutical compositions containing them | |
| FR2575158B1 (fr) | Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central | |
| IT8719882A0 (it) | Solfidril-composti per sopprimere gli effetti inibitori di prodotti di degradazione nad sull'attivita'ld-l. | |
| ATE72115T1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a- | |
| DE69109933D1 (de) | Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. | |
| ATE94758T1 (de) | Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit. | |
| EP0228034A3 (en) | Arginine and agmatine derivatives for treating protozoal infections | |
| RO95371B1 (ro) | Medicament pentru tratamentul unor afectiuni alergice cronice | |
| IT8722734A0 (it) | Apparecchiatura per la rigenerazione e depurazione del sangue. | |
| ZA89574B (en) | Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
| EP0178176A3 (en) | Tetrahydro-1,2,4-oxadiazine-5-thione derivatives |